Bill Snyder Archive — Page 104 of 119

February 6, 2014

Antioxidants promising for rare disorder

The antioxidant vitamin E prevented the buildup of toxic products in a model of a rare genetic disorder, suggesting new strategies for therapeutic development.

By Bill Snyder
February 5, 2014

Discovery may pave way for RSV vaccine

Vanderbilt University scientists have contributed to a major finding, reported this week in the journal Nature, which could lead to the first effective vaccine against respiratory syncytial virus (RSV), a significant cause of infant mortality.

By Bill Snyder
January 30, 2014

AIDS Clinical Trials Unit lands renewal of NIH funding

Vanderbilt University’s AIDS Clinical Trials Unit (ACTU) has received a seven-year grant renewal from the National Institutes of Health (NIH).

By Bill Snyder
January 24, 2014

Nine faculty honored with endowed chairs

Nine Vanderbilt University faculty members named to endowed chairs were honored for their academic achievements during a celebration Jan. 22 at the Student Life Center.

By Bill Snyder
Colleen Niswender
January 23, 2014

Autism Speaks grant boosts Rett syndrome research

Colleen Niswender, Ph.D., research associate professor of Pharmacology, has received a three-year, $450,000 grant from the autism science and advocacy organization Autism Speaks to support studies investigating a possible new treatment for Rett syndrome.

By Bill Snyder
January 23, 2014

UCSF’s Vale set to explore mechanisms of biological motility

Ron Vale, Ph.D., Lasker Award winner and co-discoverer of the molecular “motor” kinesin, will give the next Flexner Discovery Lecture at 4 p.m. on Thursday, Jan. 30, in 208 Light Hall.

By Bill Snyder